Colonic Drug Delivery

[1]  M. Gick,et al.  Irritable bowel syndrome. , 1996, Seminars in gastrointestinal disease.

[2]  Willy Verstraete,et al.  Polymers for colon specific drug delivery. , 1996 .

[3]  K. Antonin,et al.  The absorption of human calcitonin from the transverse colon of man , 1996 .

[4]  H. Stevens,et al.  The tolerability of multiple oral doses of Pulsincap™ capsules in healthy volunteers , 1996 .

[5]  K. Antonin,et al.  The colonic absorption of human calcitonin : the effects of increasing local concentration and co-administration with a protease inhibitor , 1995 .

[6]  P. Macheras,et al.  Biopharmaceutics Of Orally Administered Drugs , 1995 .

[7]  J. Dressman,et al.  Absorption of ACE inhibitors from small intestine and colon. , 1994, Journal of pharmaceutical sciences.

[8]  I. Wilding,et al.  The time clock system: a new oral dosage form for fast and complete release of drug after a predetermined lag time☆ , 1994 .

[9]  A. Gazzaniga,et al.  Oral delayed-release system for colonic specific delivery☆ , 1994 .

[10]  D. Attwood,et al.  Studies on pectin formulations for colonic drug delivery , 1994 .

[11]  A. Lloyd,et al.  AZOPOLYMERS: A MEANS OF COLON SPECIFIC DRUG DELIVERY , 1994 .

[12]  Toshio Suzuki,et al.  Colonic mucosa-specific “pro-antedrugs” for oral treatment of ulcerative colitis: design, synthesis and fate of methyl 20-glucopyranosyloxyprednisolonates , 1994 .

[13]  D. Attwood,et al.  An evaluation of pectin as a carrier for drug targeting to the colon , 1993 .

[14]  C. Samyn,et al.  Azo polymers for colon-specific drug delivery. II: Influence of the type of azo polymer on the degradation by intestinal microflora , 1993 .

[15]  D. Attwood,et al.  An in vivo investigation into the suitability of pH dependent polymers for colonic targeting , 1993 .

[16]  I. Wilding,et al.  Colonic transit of different sized tablets in healthy subjects , 1993 .

[17]  M. Rowland,et al.  Absorption of polar drugs following caecal instillation in healthy volunteers , 1992, Alimentary pharmacology & therapeutics.

[18]  C. Samyn,et al.  Azo polymers for colon-specific drug delivery , 1992 .

[19]  Clive G. Wilson,et al.  The transit rate of different-sized model dosage forms through the human colon and the effects of a lactulose-induced catharsis , 1992 .

[20]  K. Antonin,et al.  Colonic absorption of human calcitonin in man. , 1992, Clinical science.

[21]  W. Ritschel,et al.  Development and in vitro/in vivo evaluation of a colonic release capsule of vasopressin , 1992 .

[22]  R. Spiller,et al.  Scintigraphic demonstration of lactulose-induced accelerated proximal colon transit. , 1992, Gastroenterology.

[23]  S. Lynch,et al.  Absorption of human calcitonin across the rat colon in vivo. , 1992, Clinical science.

[24]  W. Ritschel,et al.  Development of a colonic release capsule dosage form and the absorption of insulin. , 1992, Methods and findings in experimental and clinical pharmacology.

[25]  T. Tozer,et al.  Drug glycosides in oral colon-specific drug delivery , 1992 .

[26]  D. Wall,et al.  (D) Routes of delivery: Case studies , 1992 .

[27]  H. Brøndsted,et al.  Polymers for colon-specific drug delivery , 1992 .

[28]  I. Wilding,et al.  The effect of fibre on gastrointestinal transit times in vegetarians and omnivores , 1991 .

[29]  R. Spiller,et al.  Pathological influences on colonic motility: implications for drug delivery , 1991 .

[30]  Clive G. Wilson,et al.  Predictive modelling of the behaviour of a controlled release buflomedil HC1 formulation using scintigraphic and pharmacokinetic data , 1991 .

[31]  M. Camilleri,et al.  Transit of solids through the human colon: regional quantification in the unprepared bowel. , 1990, The American journal of physiology.

[32]  John H. Cummings,et al.  The amount and composition of large bowel contents in man , 1990 .

[33]  U. Fuhr,et al.  Absorption differences of ciprofloxacin along the human gastrointestinal tract determined using a remote-control drug delivery device (HF-capsule). , 1989, The American journal of medicine.

[34]  S. Davis,et al.  Gastric emptying and small and large bowel transit of non-disintegrating tablets in fasted subjects , 1989 .

[35]  Clive G. Wilson,et al.  Bimodal release of ibuprofen in a sustained-release formulation: a scintigraphic and pharmacokinetic open study in healthy volunteers under different conditions of food intake , 1989 .

[36]  A. Wald,et al.  Does gender or the menstrual cycle affect colonic transit? , 1989, The American journal of gastroenterology.

[37]  S. Davis,et al.  Gastrointestinal transit of small tablets in patients with ulcerative colitis , 1988 .

[38]  N. Read,et al.  The relation between bacterial degradation of viscous polysaccharides and stool output in human beings , 1988, British Journal of Nutrition.

[39]  S. Davis,et al.  Relationship between the rate of appearance of oxprenolol in the systemic circulation and the location of an oxprenolol Oros 16/260 drug delivery system within the gastrointestinal tract as determined by scintigraphy. , 1988, British journal of clinical pharmacology.

[40]  J. Hardcastle,et al.  Measurement of gastrointestinal pH profiles in normal ambulant human subjects. , 1988, Gut.

[41]  J. Hardy,et al.  The effect of capsule size and density on transit through the proximal colon , 1988, The Journal of pharmacy and pharmacology.

[42]  W. Tremaine,et al.  Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. , 1987, The New England journal of medicine.

[43]  J. Hardy,et al.  Evaluation of an enteric‐coated delayed‐release 5‐aminosalicylic acid tablet in patients with inflammatory bowel disease , 1987, Alimentary pharmacology & therapeutics.

[44]  M. Ross,et al.  Absorption enhancement of growth hormone from the gastrointestinal tract of rats , 1986 .

[45]  D. Neckers,et al.  A new approach to the oral administration of insulin and other peptide drugs. , 1986, Science.

[46]  S. Davis,et al.  Transit of pharmaceutical dosage forms through the small intestine. , 1986, Gut.

[47]  A. G. Clark,et al.  Enema volume and spreading , 1986 .

[48]  P. Gionchetti,et al.  Retrograde spread of 5-aminosalicylic acid enemas in patients with active ulcerative colitis , 1986, Diseases of the colon and rectum.

[49]  J. Hardy,et al.  Drug delivery to the proximal colon , 1985, The Journal of pharmacy and pharmacology.

[50]  U. Klotz,et al.  Clinical Pharmacokinetics of Sulphasalazine, Its Metabolites and Other Prodrugs of 5-Aminosalicylic Acid , 1985, Clinical pharmacokinetics.

[51]  M. Scheurlen,et al.  Oxprenolol absorption in man after single bolus dosing into two segments of the colon compared with that after oral dosing. , 1985, British journal of clinical pharmacology.

[52]  K. Antonin,et al.  Colonoscopy in the investigation of drug absorption in healthy volunteers. , 1985, Gastrointestinal endoscopy.

[53]  N. Vidon,et al.  Investigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon. , 1985, British journal of clinical pharmacology.

[54]  Clive G. Wilson,et al.  The effect of food on the gastrointestinal transit of pellets and an osmotic device (Osmet) , 1984 .

[55]  M. Peppercorn.  Sulfasalazine: Pharmacology, Clinical Use, Toxicity, and Related New Drug Development , 1984 .

[56]  D. Taylor,et al.  On the intestinal transit of a single non-disintegrating object , 1984 .

[57]  D. Friend,et al.  A colon-specific drug-delivery system based on drug glycosides and the glycosidases of colonic bacteria. , 1984, Journal of medicinal chemistry.

[58]  A. Onderdonk,et al.  A polymeric drug for treatment of inflammatory bowel disease. , 1983, Journal of medicinal chemistry.

[59]  R. Ryder,et al.  Colonic release of 5-amino salicylic acid from an oral preparation in active ulcerative colitis. , 1983, British journal of clinical pharmacology.

[60]  Clive G. Wilson,et al.  Monitoring antacid preparations in the stomach using gamma scintigraphy , 1983 .

[61]  B. Ehrlich,et al.  LITHIUM ABSORPTION: IMPLICATIONS FOR SUSTAINED-RELEASE LITHIUM PREPARATIONS , 1983, The Lancet.

[62]  J. Rhodes,et al.  An oral preparation to release drugs in the human colon. , 1982, British journal of clinical pharmacology.

[63]  D. Powell,et al.  Barrier function of epithelia. , 1981, The American journal of physiology.

[64]  M. Farthing,et al.  Retrograde spread of hydrocortisone containing foam given intrarectally in ulcerative colitis. , 1979, British medical journal.

[65]  J. B. Wyman,et al.  Variability of colonic function in healthy subjects. , 1978, Gut.

[66]  W. James,et al.  COLONIC RESPONSE TO DIETARY FIBRE FROM CARROT, CABBAGE, APPLE, BRAN, AND GUAR GUM , 1978, The Lancet.

[67]  Y. Watanabe,et al.  [Relationship between quality and serum level after the oral administration of commercial erythromycin tablets in man (author's transl)]. , 1977, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[68]  Martindale.,et al.  THE EXTRA PHARMACOPOEIA , 1937 .

[69]  J. Newton,et al.  Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using 5-aminosalicylic acid pellets , 1996 .

[70]  J. Newton,et al.  Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using glucose pellets , 1996 .

[71]  Y. Chien,et al.  Systemic delivery of peptides and proteins across absorptive mucosae. , 1996, Critical reviews in therapeutic drug carrier systems.

[72]  F. Giordano,et al.  Evaluation of low viscosity HPMC as retarding coating material in the preparation of a time-based oral colon specific delivery system , 1995 .

[73]  B. Říhová,et al.  Bioadhesive N-(2-hydroxypropyl) methacrylamide copolymers for colon-specific drug delivery , 1994 .

[74]  S. Lynch,et al.  Enhancement of human calcitonin absorption across the rat colon in vivo , 1994 .

[75]  D. Fox,et al.  Osmotic systems for colon-targeted drug delivery , 1993 .

[76]  J. Dressman,et al.  Oral absorption of peptides and proteins , 1992 .

[77]  W. Curatolo,et al.  C) Means to enhance penetration , 1992 .

[78]  S. I. Kim,et al.  Degradation of azo-containing polyurethane by the action of intestinal flora : its mechanism and application as a drug delivery system , 1992 .

[79]  M. Camilleri,et al.  Unprepared human colon does not discriminate between solids and liquids. , 1991, The American journal of physiology.

[80]  A. Elias,et al.  Insulin and C-peptide levels following oral administration of insulin in intestinal-enzyme protected capsules. , 1991, General pharmacology.

[81]  T. Berglindh,et al.  Pharmacology of olsalazine. , 1988, Scandinavian journal of gastroenterology. Supplement.

[82]  C. P. Willoughby,et al.  Double-blind comparison of olsalazine and sulphasalazine in active ulcerative colitis. , 1988, Scandinavian journal of gastroenterology. Supplement.

[83]  G. Järnerot,et al.  Long-term treatment with olsalazine for ulcerative colitis: safety and relapse prevention: a follow-up study. , 1988, Scandinavian journal of gastroenterology. Supplement.

[84]  S F Phillips,et al.  Simplified assessment of segmental colonic transit. , 1987, Gastroenterology.

[85]  D. Friend,et al.  Drug glycosides: potential prodrugs for colon-specific drug delivery. , 1985, Journal of medicinal chemistry.